Herbas VPB

Print
EN | LT
LT - METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION
EN - METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/17 (2006.01)
A61K 38/177 (2013.01)
A61K 48/00 (2006.01)
C07K2319/30 (2013.01)
A61P 25/28 (2006.01)
C07K 14/70596 (2013.01)
C07K 14/705 (2006.01)
A61K 47/68 (2017.08)
A61K 47/68 (2017.01)
A61P 25/28 (2018.01)
A61P 25/16 (2006.01)
A61P 25/16 (2018.01)
European patent
(11) Number of the document 3624838
(13) Kind of document T
(96) European patent application number 18801838.6
Date of filing the European patent application 2018-05-15
(97) Date of publication of the European application 2020-03-25
(45) Date of publication and mention of the grant of the patent 2023-01-25
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2018/032699
Date 2018-05-15
PCT application publication
(87) Number WO 2018/213266
Date 2018-11-22
Priority applications
(30) Number Date Country code
201762506135 P 2017-05-15 US
Inventors
(72)
LIU, Yang , US
ZHENG, Pan , US
LI, Ning , US
DEVENPORT, Martin , US
Grantee
(73) Oncoimmune, Inc. , 9430 Key West Avenue Suite 113, Rockville, Maryland 20850, US
Children's National Medical Center , 111 Michigan Avenue N.W., Washington, DC 20010, US
Title
(54) METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION
  METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION